Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dexcom (DXCM) Cash from Operations (2016 - 2025)

Dexcom (DXCM) has disclosed Cash from Operations for 16 consecutive years, with 294000000.0 as the latest value for Q4 2025.

  • Quarterly Cash from Operations fell 2.46% to 294000000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 1440700000.0 through Dec 2025, up 45.6% year-over-year, with the annual reading at 1440700000.0 for FY2025, 45.6% up from the prior year.
  • Cash from Operations for Q4 2025 was 294000000.0 at Dexcom, down from 659900000.0 in the prior quarter.
  • The five-year high for Cash from Operations was 659900000.0 in Q3 2025, with the low at 27800000.0 in Q1 2021.
  • Average Cash from Operations over 5 years is 214535000.0, with a median of 194900000.0 recorded in 2023.
  • Peak annual rise in Cash from Operations hit 1363.16% in 2021, while the deepest fall reached 60.03% in 2021.
  • Over 5 years, Cash from Operations stood at 105800000.0 in 2021, then grew by 25.24% to 132500000.0 in 2022, then rose by 0.83% to 133600000.0 in 2023, then skyrocketed by 125.6% to 301400000.0 in 2024, then dropped by 2.46% to 294000000.0 in 2025.
  • According to Business Quant data, Cash from Operations over the past three periods came in at 294000000.0, 659900000.0, and 303000000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.